FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) | MicrobiomeTrials← Back to trialsNCT07111065
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2030-11-03
Enrollment target: 300 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Idiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase SyndromeImmune-Mediated Necrotizing MyopathyJuvenile DermatomyositisJuvenile PolymyositisJuvenile Idiopathic Inflammatory Myopathy (JIIM)Juvenile Myositis
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Infl…
Orange, United StatesEst. completion Jul 2028
The purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with acti…
Phoenix, United StatesEst. completion Sep 4, 2025